NextCure

Four biotech companies announce pricings of IPOs, looking to raise more than $300M

NextCure, Milestone Pharmaceuticals, Cortexyme and Axcella Health all said Wednesday that they would begin trading on the Nasdaq Thursday.

By Alaric DeArment

Unlocking Transparency in PBM Pricing

The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.

eBook

Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience

This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.

By Care Logistics